Symbiotix, Inc. has been acquired by Havas Health, Inc.
November 2015 — Symbiotix, a US medical communications and marketing agency, has been sold to Paris-based Havas and has become part of Havas Health, a leading, global healthcare marketing network. Financial details were not disclosed. Symbiotix leverages science and strategy to engage physicians and other healthcare professionals (HCPs).
Symbiotix was founded in 1998 by Tim and Jo Ann Rice in Lexington, Kentucky. The company will continue to operate from Lexington, with the Rices serving as CEO and COO respectively. Approximately 40 percent of Symbiotix’s staff are based in field offices near major clients in California, Illinois, Pennsylvania and the New York Tristate area.
Havas Health owns and operates health and wellness communication networks. The company offers advertising, public relations, event promotion, digital marketing, direct-to-patient, consulting, DTC/DTP and B2B services. It also engages in educating medical and consumer communities about disease and treatment awareness, and provides strategic consultation for optimizing communications to HCPs, payers, patients and consumers. The addition of Symbiotix to its portfolio will help Havas Health meet the demand for enhanced medical communications.
Our role in the transaction
Oaklins' media specialist team in New York was the exclusive financial advisor to Symbiotix in this transaction.
Talk to the deal team
Reed Phillips
Oaklins DeSilva+Phillips
Related deals
Comtax has been acquired by Ryan
Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreNextalia has acquired a majority stake in Witapp
Nextalia SGR S.p.A. has acquired a majority stake in Witapp S.r.l., an Italian company specializing in software development for the digitization of healthcare infrastructure. The acquisition strengthens Nextalia’s track record in technology companies serving the public sector and supports its strategy of investing in businesses operating at the intersection of healthcare digitization and the modernization of public services.
Learn more